Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued

GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announce

AKRON, Ohio--(BUSINESS WIRE)-- #BIO2026--BioMendics, LLC, a clinical-stage biotechnology company dev

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

Emergent BioSolutions Inc. (EBS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reachi

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has been awarded a contract modification va

GAITHERSBURG, Md., May 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today ann

GAITHERSBURG, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced

https://www.cdc.gov/ebola/situation-summary/index.html

Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi Food a

GAITHERSBURG, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biode

Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak.

Emergent BioSolutions Inc. (EBS) Q1 2026 Earnings Call Transcript

Emergent BioSolutions (NYSE:EBS) sees Q2 sales of $170.000 million-$185.000 million vs $186.000 mill

Emergent BioSolutions (NYSE:EBS) affirms FY2026 sales outlook from $720.000 million-$760.000 million

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $0.21 per share which beat the analy

GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today r

Emergent BioSolutions Inc. (NYSE:EBS) today announced that Singapore's Health Sciences Authority

GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today a

The executed agreement is valued at approximately $50 million, of which $36 million is contingent on

GAITHERSBURG, Md., April 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today a

WINNIPEG, Manitoba, April 29, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (NYSE: EBS) anno

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has entered into an agreement with Substiph

GAITHERSBURG, Md. and GENEVA, April 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: E

The April/May 2026 Ben Graham All-Star Value Dogs list highlights 14 'safer,' fair-priced large-cap

GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will ho

Refinancing extends maturities, reduces interest expense and positions Emergent for durable, long-te

Emergent BioSolutions (NYSE:EBS) announced that it has partnered with the B.C. Provincial Health Ser

WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) annou

New product offerings and educational initiative, Ready to Rescue, aim to increase access and adopti

GAITHERSBURG, Md., April 02, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a glob

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured a contract award valued at app

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Emergent BioSolutions (NYSE:EBS) wit

U.S. stocks down mid-trading, Nasdaq falls 1%. Dow down 1.40%, S&P 500 falls 0.74%. Dell shares

US stocks traded lower, Dow down 600 points. Nasdaq and S&P also fell. Consumer staples up, tech

Emergent BioSolutions (NYSE:EBS) sees FY2026 sales of $720.000 million-$760.000 million vs $1.155 bi

Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.43) per share which missed the ana

Emergent BioSolutions Inc. (EBS) stock rose Friday as FDA approved new multipack configurations of o

Today, Emergent BioSolutions (NYSE:EBS) announced that the U.S. Food and Drug Administration (FDA) h